Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With Olanzapine (GWMD09126)

This study has been terminated.

(The Chief Investigator and the Sponsor have concluded that it will not be possible to complete the enrolment in any meaningful timeframe.)

Sponsor:

Information provided by (Responsible Party):

GW Pharmaceuticals Ltd.

ClinicalTrials.gov Identifier:

NCT01491490

First received: December 5, 2011

Last updated: March 11, 2013

Last verified: March 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	October 2012
Primary Completion Date:	October 2012 (Final data collection date for primary outcome measure)